Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma

Surgery (United States)

Volumn 155, Issue 3, 2014, Pages 512-521

  Cucchetti, Alessandro ^a   Qiao, Guo Liang ^b   Cescon, Matteo ^a   Li, Jun ^b   Xia, Yong ^b   Ercolani, Giorgio ^a   Shen, Feng ^b   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANATOMIC RESECTION; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONANATOMIC RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR INVASION;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84894049519     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.10.009     Document Type: Article

References (26)

1. H.B. El-Serag Hepatocellular carcinoma: an epidemiologic view J Clin Gastroenterol 35 2002 S72 S78
2. D. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 2001 533 543
3. S.T. Fan, C.M. Lo, and C.L. Liu et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths Ann Surg 229 1999 322 330
4. A. Cucchetti, M. Zanello, M. Cescon, G. Ercolani, M. Del Gaudio, and M. Ravaioli et al. Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years Ann Surg Oncol 18 2011 1630 1637
5. J.H. Park, K.C. Koh, M.S. Choi, J.H. Lee, B.C. Yoo, and S.W. Paik et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma Am J Surg 192 2006 29 33
6. T. Kamiyama, K. Nakanishi, H. Yokoo, H. Kamachi, M. Tahara, and T. Kakisaka et al. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma World J Surg Oncol 10 2012 107
7. A. Cucchetti, M. Cescon, G. Ercolani, E. Bigonzi, G. Torzilli, and A.D. Pinna A comprehensive meta-regression analysis on outcome of anatomic resection versus non-anatomic resection for hepatocellular carcinoma Ann Surg Oncol 19 2012 3697 3705
8. P.C. Austin A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003 Stat Med 27 2008 2037 2049
9. G. Huang, E.C. Lai, W.Y. Lau, W.P. Zhou, F. Shen, and Z.Y. Pan et al. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels Ann Surg 257 2013 490 505
10. H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
11. U.C. Nzeako, Z.D. Goodman, and K.G. Ishak Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma Cancer 76 1995 579 588
12. J.N. Vauthey, G.Y. Lauwers, N.F. Esnaola, K.A. Do, J. Belghiti, and N. Mirza et al. Simplified staging for hepatocellular carcinoma J Clin Oncol 20 2002 1527 1536
13. A.L. Cheng, Y.K. Kang, Z. Chen, C.J. Tsao, S. Qin, and J.S. Kim et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34
14. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc et al. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
15. S.T. Normand, M.B. Landrum, E. Guadagnoli, J.Z. Ayanian, T.J. Ryan, and P.D. Cleary et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 54 2001 387 398
16. A. Cucchetti, F. Piscaglia, A.D. Grigioni, M. Ravaioli, M. Cescon, and M. Zanello et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study J Hepatol 52 2010 880 888
17. A. Colecchia, E. Scaioli, L. Montrone, A. Vestito, A.R. Di Biase, and M. Pieri et al. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment J Hepatol 54 2011 300 305
18. T.M. Pawlik, A.L. Gleisner, R.A. Anders, L. Assumpcao, W. Maley, and M.A. Choti Preoperative assessment of hepatocellular carcinoma tumour grade using needle biopsy: implications for transplant eligibility Ann Surg 245 2007 435 442
19. B.K. Kim, K.H. Han, Y.N. Park, M.S. Park, K.S. Kim, and J.S. Choi et al. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma J Surg Oncol 97 2008 246 252
20. T.M. Pawlik, K.A. Delman, J.N. Vauthey, D.M. Nagorney, I.O. Ng, and I. Ikai et al. Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 2005 1086 1092
21. K. Nasu, Y. Kuroki, T. Tsukamoto, H. Nakajima, K. Mori, and M. Minami Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade AJR Am J Roentgenol 193 2009 438 444
22. K. Saito, F. Moriyasu, K. Sugimoto, R. Nishio, T. Saguchi, and S. Akata et al. Histological grade of differentiation of hepatocellular carcinoma: comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT J Med Imaging Radiat Oncol 56 2012 261 269
23. C.D. Witjes, F.E. Willemssen, J. Verheij, S.J. van der Veer, B.E. Hansen, and C. Verhoef et al. Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI J Magn Reson Imaging 36 2012 641 647
24. R. Stigliano, L. Marelli, D. Yu, N. Davies, D. Patch, and A.K. Burroughs Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC Cancer Treat Rev 33 2007 437 447
25. S. Eguchi, T. Kanematsu, S. Arii, M. Okazaki, K. Okita, and M. Omata et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey Surgery 143 2008 469 475
26. Prognostic impact of anatomical resection vs. non-anatomical resection for HCC (ARversusNAR) [cited 2013 May 31]. Available from: http:// clinicaltrials.gov/ct2/show/NCT01236989.